āļ„āļđāđˆāļĄāļ·āļ­āļ—āļēāļ‡āđ€āļ—āļ„āļ™āļīāļ„

Virtual Screening and Molecular Docking

Virtual screening ranks a large set of compounds for follow-up, while molecular docking estimates plausible poses and scoring values for a ligand inside a target structure.

āļŸāļąāļ‡āļ„āļģāđāļ™āļ°āļ™āļģāļ™āļĩāđ‰āļšāļĢāļĢāļĒāļēāļĒāđ‚āļ”āļĒ AI · ~3 min

āļšāļ™āļŦāļ™āđ‰āļēāļ™āļĩāđ‰āļ­āđˆāļēāļ™ 3 āļ™āļēāļ—āļĩ
  1. āļ āļēāļžāļĢāļ§āļĄ
  2. āđ€āļˆāļēāļ°āļĨāļķāļ
  3. āļāļēāļĢāđƒāļŠāđ‰āļ‡āļēāļ™āļˆāļĢāļīāļ‡āđƒāļ™āđ‚āļĨāļāđāļŦāđˆāļ‡āļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļˆāļĢāļīāļ‡
  4. The Future of Virtual Screening and Molecular Docking
  5. āļāļēāļĢāļ™āļģāđ„āļ›āļ›āļāļīāļšāļąāļ•āļī
  6. āļŠāļģāļĢāļ§āļˆāļ•āđˆāļ­āđ„āļ›
  7. āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āļ āļēāļžāļĢāļ§āļĄ

These calculations can prioritize experiments but do not establish binding, biological activity, safety, or clinical usefulness.

āđ€āļˆāļēāļ°āļĨāļķāļ

Virtual screening uses computational methods to prioritize compounds for experimental follow-up. Ligand-based approaches compare candidate molecules with known actives; structure-based approaches use a target structure. Molecular docking is a structure-based method that searches for plausible ligand poses in a binding site and scores them according to an approximate energy or interaction function. A typical docking workflow prepares a protein structure and ligand representations, defines a search region, samples orientations and conformations, and ranks resulting poses. Tools such as AutoDock Vina use a scoring function and optimization procedure to estimate favorable binding arrangements. The score is a model output under specified assumptions, not a measured binding free energy. It is sensitive to protonation, tautomer choice, receptor conformation, solvent treatment, and the search box. Virtual screening can help reduce an enormous chemical catalog to candidates worth closer inspection. Enrichment tests ask whether known actives rank above decoys or inactives under a defined benchmark. But retrospective enrichment can be inflated by data leakage, scaffold similarity, or an unrealistic decoy set. Use scaffold-aware splits and external test sets when evaluating predictive workflows. Docking is not a substitute for molecular dynamics, binding experiments, or cell assays. A plausible pose can still represent a false positive; a poor score can miss a real binder. Proteins move, water molecules and cofactors matter, and assay conditions may differ from a static structure. Consider chemical feasibility, solubility, synthesis, selectivity, toxicity, and experimental reproducibility after computational ranking. The best use is triage. Combine structure-based scores with ligand-based models, human review, orthogonal assays, and portfolio diversity. Track each prediction's structure source, preparation settings, model, and rationale so results can be reproduced. Present a score as evidence for prioritization, never as proof that a compound will become a drug.

āļāļēāļĢāđƒāļŠāđ‰āļ‡āļēāļ™āļˆāļĢāļīāļ‡āđƒāļ™āđ‚āļĨāļāđāļŦāđˆāļ‡āļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļˆāļĢāļīāļ‡

A research team docks a curated compound library into a protein structure and sends a small, diverse shortlist for laboratory testing.

An analyst compares docking scores with known active and inactive compounds to check whether the workflow can enrich relevant candidates.

A chemist inspects predicted poses for clashes and interactions rather than sorting solely by the lowest score.

A screening pipeline records receptor preparation, protonation assumptions, search region, software version, and compound identifiers.

The Future of Virtual Screening and Molecular Docking

Structure-based screening may benefit from improved protein structures, flexible-receptor methods, and learned scoring functions. Better computational throughput can screen larger libraries, but the limiting step often remains experimental follow-up and synthesis. Future pipelines can connect ranked candidates with provenance, assay data, and chemical feasibility checks. Docking scores will remain one input in a broader evidence chain. Better structures and learned scoring may improve prioritization, but experimental capacity remains a constraint. Results should be linked to assays so future models can be evaluated prospectively.

āļāļēāļĢāļ™āļģāđ„āļ›āļ›āļāļīāļšāļąāļ•āļī

āļ—āļģāđ„āļĄāļĄāļąāļ™āļ–āļķāļ‡āļŠāļģāļ„āļąāļ

  • āļ•āđ‰āļ™āļ—āļļāļ™āđāļĨāļ°āļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“. āļāļēāļĢāļ•āļąāļ”āļŠāļīāļ™āđƒāļˆāļ”āđ‰āļēāļ™āļŠāļ–āļēāļ›āļąāļ•āļĒāļāļĢāļĢāļĄāļ‚āļąāļšāđ€āļ„āļĨāļ·āđˆāļ­āļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāđāļĨāļ°āļ•āđ‰āļ™āļ—āļļāļ™āļāļēāļĢāļ”āļģāđ€āļ™āļīāļ™āļ‡āļēāļ™āđ€āļ›āđ‡āļ™āđ€āļ§āļĨāļēāļŦāļĨāļēāļĒāļ›āļĩ
  • āļāļēāļĢāļ•āļąāļ”āļŠāļīāļ™āđƒāļˆāļ—āļĩāđˆāļŠāļąāļ”āđ€āļˆāļ™āļĒāļīāđˆāļ‡āļ‚āļķāđ‰āļ™. āļāļēāļĢāļĻāļķāļāļĐāļēāļ”āđ‰āļēāļ™āđ€āļ—āļ„āļ™āļīāļ„āļŠāđˆāļ§āļĒāđƒāļŦāđ‰āļ—āļĩāļĄāđ€āļĨāļ·āļ­āļāļāļĨāļļāđˆāļĄāļ—āļĩāđˆāđ€āļŦāļĄāļēāļ°āļŠāļĄ āđ„āļĄāđˆāđƒāļŠāđˆāđāļ„āđˆāļāļĨāļļāđˆāļĄāđƒāļŦāļĄāđˆāļĨāđˆāļēāļŠāļļāļ”
  • āļāļēāļĢāļ„āļ§āļšāļ„āļļāļĄāļ„āļļāļ“āļ āļēāļž. āļ•āļąāļ§āđ€āļĨāļ·āļ­āļāļ—āļēāļ‡āļ§āļīāļĻāļ§āļāļĢāļĢāļĄāļ—āļĩāđˆāļ”āļĩāļāļ§āđˆāļēāļˆāļ°āļŠāđˆāļ§āļĒāļĨāļ”āđ€āļŦāļ•āļļāļāļēāļĢāļ“āđŒāļ”āđ‰āļēāļ™āļ„āļ§āļēāļĄāļ™āđˆāļēāđ€āļŠāļ·āđˆāļ­āļ–āļ·āļ­āđƒāļ™āļāļēāļĢāļœāļĨāļīāļ•

āļĢāļ°āļ§āļąāļ‡

  • āļāļēāļĢāđ€āļžāļīāđˆāļĄāļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāđ€āļāļ“āļ‘āđŒāļĄāļēāļ•āļĢāļāļēāļ™āļŦāļ™āļķāđˆāļ‡āļĢāļēāļĒāļāļēāļĢāļŠāļēāļĄāļēāļĢāļ–āļ‹āđˆāļ­āļ™āļˆāļļāļ”āļ­āđˆāļ­āļ™āļ‚āļ­āļ‡āļĢāļ°āļšāļšāđƒāļ™āļ§āļ‡āļāļ§āđ‰āļēāļ‡āđ„āļ”āđ‰
  • āļ•āđ‰āļ™āļ—āļļāļ™āđ‚āļ„āļĢāļ‡āļŠāļĢāđ‰āļēāļ‡āļžāļ·āđ‰āļ™āļāļēāļ™āđāļĨāļ°āļāļēāļĢāļšāļģāļĢāļļāļ‡āļĢāļąāļāļĐāļēāļĄāļąāļāļ–āļđāļāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ•āđˆāļģāđ„āļ›
  • āļŠāđˆāļ­āļ‡āļ§āđˆāļēāļ‡āļ”āđ‰āļēāļ™āļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒāđāļĨāļ°āļ„āļ§āļēāļĄāļŠāļēāļĄāļēāļĢāļ–āđƒāļ™āļāļēāļĢāļŠāļąāļ‡āđ€āļāļ•āļŠāļēāļĄāļēāļĢāļ–āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™āđ„āļ”āđ‰āđ€āļĄāļ·āđˆāļ­āļĢāļ°āļšāļšāļĄāļĩāļ„āļ§āļēāļĄāļ‹āļąāļšāļ‹āđ‰āļ­āļ™āļĄāļēāļāļ‚āļķāđ‰āļ™

āļ‚āļąāđ‰āļ™āļ•āļ­āļ™āļ•āđˆāļ­āđ„āļ›

  1. āļāļģāļŦāļ™āļ”āđ€āļ›āđ‰āļēāļŦāļĄāļēāļĒāđ€āļ§āļĨāļēāđāļāļ‡ āļ„āļļāļ“āļ āļēāļž āđāļĨāļ°āļ•āđ‰āļ™āļ—āļļāļ™āļāđˆāļ­āļ™āļ™āļģāđ„āļ›āđƒāļŠāđ‰āļ‡āļēāļ™
  2. āđ€āļāļ“āļ‘āđŒāļĄāļēāļ•āļĢāļāļēāļ™āļ āļēāļĒāđƒāļ•āđ‰āļŠāļ āļēāļ§āļ°āđ‚āļŦāļĨāļ”āđāļĨāļ°āļ‚āđ‰āļ­āļĄāļđāļĨāļˆāļĢāļīāļ‡
  3. āļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāđ€āļ„āļĢāļ·āđˆāļ­āļ‡āļĄāļ·āļ­āđ€āļžāļ·āđˆāļ­āļŦāļēāļ‚āđ‰āļ­āļœāļīāļ”āļžāļĨāļēāļ” āļāļēāļĢāđ€āļšāļĩāđˆāļĒāļ‡āđ€āļšāļ™ āđāļĨāļ°āļœāļĨāļāļĢāļ°āļ—āļšāļ•āđˆāļ­āļœāļđāđ‰āđƒāļŠāđ‰
  4. āđ€āļ•āļĢāļĩāļĒāļĄāđ€āļŠāđ‰āļ™āļ—āļēāļ‡āļāļēāļĢāļĒāđ‰āļ­āļ™āļāļĨāļąāļšāđāļĨāļ°āļāļēāļĢāļ•āļ­āļšāļŠāļ™āļ­āļ‡āļ•āđˆāļ­āđ€āļŦāļ•āļļāļāļēāļĢāļ“āđŒāļāđˆāļ­āļ™āļ›āļĢāļąāļšāļ‚āļ™āļēāļ”

āļŠāļģāļĢāļ§āļˆāļ•āđˆāļ­āđ„āļ›

āļˆāļ”āļŦāļĄāļēāļĒāļ‚āđˆāļēāļ§āļŸāļĢāļĩ

āļĢāļąāļšāļŠāļĢāļļāļ› AI āļĢāļēāļĒāļ§āļąāļ™

āđ€āļĢāļ·āđˆāļ­āļ‡āļĢāļēāļ§ AI āļ—āļĩāđˆāļ•āļĢāļ§āļˆāļŠāļ­āļšāđāļĨāđ‰āļ§ 3 āđ€āļĢāļ·āđˆāļ­āļ‡āļ—āļļāļāļ§āļąāļ™āļ—āļģāļ‡āļēāļ™ āđ€āļŠāđ‰āļē, āđ€āļ‚āļĩāļĒāļ™āđ€āļ›āđ‡āļ™āļ āļēāļĐāļēāļ­āļąāļ‡āļāļĪāļĐāļ˜āļĢāļĢāļĄāļ”āļē āļŸāļĢāļĩāļ•āļĨāļ­āļ”āđ„āļ› āđ„āļĄāđˆāļĄāļĩāđ‚āļ†āļĐāļ“āļē

āļ­āļĩāđ€āļĄāļĨāļŦāļ™āļķāđˆāļ‡āļ‰āļšāļąāļšāļ—āļļāļāļ§āļąāļ™āļ—āļģāļ‡āļēāļ™ āļĒāļāđ€āļĨāļīāļāļāļēāļĢāļŠāļĄāļąāļ„āļĢāđƒāļ™āļ„āļĨāļīāļāđ€āļ”āļĩāļĒāļ§ āđ€āļĢāļēāđ„āļĄāđˆāđ€āļ„āļĒāļ‚āļēāļĒāļŦāļĢāļ·āļ­āđāļŠāļĢāđŒāļ—āļĩāđˆāļ­āļĒāļđāđˆāļ­āļĩāđ€āļĄāļĨāļ‚āļ­āļ‡āļ„āļļāļ“

āļ—āļ”āļŠāļ­āļšāļ•āļąāļ§āđ€āļ­āļ‡

Take the Virtual Screening and Molecular Docking quiz

āļ‚āđ‰āļ­āđ€āļŠāļ™āļ­āđāļ™āļ°āļ—āļąāļ™āļ—āļĩāļŠāļģāļŦāļĢāļąāļšāļ—āļļāļāļ„āļģāļ•āļ­āļš āđāļĨāļ°āđƒāļšāļĢāļąāļšāļĢāļ­āļ‡āļ—āļĩāđˆāļŠāļēāļĄāļēāļĢāļ–āđāļŠāļĢāđŒāđ„āļ”āđ‰āļžāļĢāđ‰āļ­āļĄ ID āļ—āļĩāđˆāļ•āļĢāļ§āļˆāļŠāļ­āļšāđ„āļ”āđ‰āđ€āļĄāļ·āđˆāļ­āļ„āļļāļ“āļœāđˆāļēāļ™āļŦāļĨāļąāļāļŠāļđāļ•āļĢ

āđ€āļĢāļīāđˆāļĄāđāļšāļšāļ—āļ”āļŠāļ­āļš

āļŠāļ™āļąāļšāļŠāļ™āļļāļ™āļāļēāļĢāļĻāļķāļāļĐāļē AI āļŸāļĢāļĩ AI Understanding āđ€āļ›āđ‡āļ™āļ­āļ‡āļ„āđŒāļāļĢāđ„āļĄāđˆāđāļŠāļ§āļ‡āļŦāļēāļœāļĨāļāļģāđ„āļĢ 501(c)(3) — āđ„āļĄāđˆāļĄāļĩāđ‚āļ†āļĐāļ“āļē āđ„āļĄāđˆāļĄāļĩāļāļģāđāļžāļ‡āđ€āļ‡āļīāļ™, āļ•āļĨāļ­āļ”āđ„āļ› āļšāļĢāļīāļˆāļēāļ„

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

What is Virtual Screening and Molecular Docking?

Virtual screening ranks a large set of compounds for follow-up, while molecular docking estimates plausible poses and scoring values for a ligand inside a target structure. These calculations can prioritize experiments but do not establish binding, biological activity, safety, or clinical usefulness.

What does molecular docking estimate?

Docking searches for possible binding arrangements and evaluates them with an approximate scoring function.

What does a favorable docking score establish?

A score is evidence for prioritization, not experimental confirmation.

Why use scaffold-aware or external test splits for screening models?

Related molecules in both splits can make a model appear more general than it is.

Which ranking behavior does enrichment testing assess?

Enrichment evaluates retrieval of known actives within a ranked set.

Why can two docking scores from different tools be hard to compare directly?

Different functions and settings produce values on different scales.

āđ€āļĢāļĩāļĒāļ™āļĢāļđāđ‰āļ•āđˆāļ­āđ„āļ›

āļ„āļģāđāļ™āļ°āļ™āļģāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡

āļ„āļģāđāļ™āļ°āļ™āļģāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ—āļĩāđˆāđ€āļĨāļ·āļ­āļāļŠāļģāļŦāļĢāļąāļšāļŦāļąāļ§āļ‚āđ‰āļ­āļ™āļĩāđ‰

āļ•āđˆāļ­āđ„āļ›āļ„āļģāđāļ™āļ°āļ™āļģāļ•āđˆāļ­āđ„āļ›

āļāļēāļĢāđ€āļ›āđ‡āļ™āļ•āļąāļ§āđāļ—āļ™āļĢāļ°āļ”āļąāļšāđ‚āļĄāđ€āļĨāļāļļāļĨāļŠāļģāļŦāļĢāļąāļšāļāļēāļĢāđ€āļĢāļĩāļĒāļ™āļĢāļđāđ‰āļ‚āļ­āļ‡āđ€āļ„āļĢāļ·āđˆāļ­āļ‡

āđ€āļ—āļ„āļ™āļīāļ„

āļĢāļąāļšāđƒāļšāļĢāļąāļšāļĢāļ­āļ‡ AI āļŸāļĢāļĩāļŦāļĨāļąāļāļŠāļđāļ•āļĢāđāļĨāļ°āļāļēāļĢāļŠāļ­āļšāļŠāļąāđ‰āļ™ āđ† āļŸāļĢāļĩ āđ„āļĄāđˆāļĄāļĩāļ„āđˆāļēāđƒāļŠāđ‰āļˆāđˆāļēāļĒ āđ„āļĄāđˆāļĄāļĩāļšāļąāļ•āļĢāđ€āļ„āļĢāļ”āļīāļ• āļ›āļĢāļ°āļĄāļēāļ“ 2.5 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āđ€āļĢāļīāđˆāļĄāļ•āđ‰āļ™āļŸāļĢāļĩ →